155 related articles for article (PubMed ID: 38018029)
21. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in preventing dental plaque.
Lotufo R; Calil CM; Feng HS; Sekiguchi RT; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):50-4. PubMed ID: 19591337
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a new mouth rinse formulation based on 0.07% cetylpyridinium chloride in the control of plaque and gingivitis: a 6-month randomized clinical trial.
Costa X; Laguna E; Herrera D; Serrano J; Alonso B; Sanz M
J Clin Periodontol; 2013 Nov; 40(11):1007-15. PubMed ID: 24024983
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the effects of cetylpyridinium chloride with an essential oil mouth rinse on dental plaque and gingivitis - a six-month randomized controlled clinical trial.
Albert-Kiszely A; Pjetursson BE; Salvi GE; Witt J; Hamilton A; Persson GR; Lang NP
J Clin Periodontol; 2007 Aug; 34(8):658-67. PubMed ID: 17635245
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the effectiveness of mouthwashes in reducing cariogenic biofilm in orthodontic patients: a systematic review.
Pithon MM; Sant'Anna LI; Baião FC; dos Santos RL; Coqueiro Rda S; Maia LC
J Dent; 2015 Mar; 43(3):297-308. PubMed ID: 25572792
[TBL] [Abstract][Full Text] [Related]
25. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
PeerJ; 2023; 11():e15080. PubMed ID: 38130922
[TBL] [Abstract][Full Text] [Related]
26. Effect of different mouthrinses on morning breath.
van Steenberghe D; Avontroodt P; Peeters W; Pauwels M; Coucke W; Lijnen A; Quirynen M
J Periodontol; 2001 Sep; 72(9):1183-91. PubMed ID: 11577950
[TBL] [Abstract][Full Text] [Related]
27. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque.
Mankodi S; Bauroth K; Witt JJ; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A
Am J Dent; 2005 Jul; 18 Spec No():9A-14A. PubMed ID: 16178130
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of a low-concentration chlorhexidine mouth rinse in non-compliant periodontitis patients attending a supportive periodontal care programme: a randomized clinical trial.
Escribano M; Herrera D; Morante S; Teughels W; Quirynen M; Sanz M
J Clin Periodontol; 2010 Mar; 37(3):266-75. PubMed ID: 20088984
[TBL] [Abstract][Full Text] [Related]
29. Effect of toothpaste on the plaque inhibitory properties of a cetylpyridinium chloride mouth rinse.
Sheen S; Eisenburger M; Addy M
J Clin Periodontol; 2003 Mar; 30(3):255-60. PubMed ID: 12631184
[TBL] [Abstract][Full Text] [Related]
30. An alcohol-free therapeutic mouthrinse with cetylpyridinium chloride (CPC)--the latest advance in preventive care: Crest Pro-Health Rinse.
White DJ
Am J Dent; 2005 Jul; 18 Spec No():3A-8A. PubMed ID: 16178129
[No Abstract] [Full Text] [Related]
31. A randomized clinical trial on the short-term clinical and microbiological effects of the adjunctive use of a 0.05% chlorhexidine mouth rinse for patients in supportive periodontal care.
Santos S; Herrera D; López E; O'Connor A; González I; Sanz M
J Clin Periodontol; 2004 Jan; 31(1):45-51. PubMed ID: 15058374
[TBL] [Abstract][Full Text] [Related]
32. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in reducing dental plaque.
Hernandez-Cott PL; Elias Boneta A; Stewart B; DeVizio W; Proskin HM
J Clin Dent; 2009; 20(2):39-44. PubMed ID: 19591335
[TBL] [Abstract][Full Text] [Related]
33. A combined therapeutic approach to manage oral halitosis: a 3-month prospective case series.
Roldán S; Herrera D; O'Connor A; González I; Sanz M
J Periodontol; 2005 Jun; 76(6):1025-33. PubMed ID: 15948701
[TBL] [Abstract][Full Text] [Related]
34. Antibacterial and antiplaque effects of a novel, alcohol-free oral rinse with cetylpyridinium chloride.
Witt J; Ramji N; Gibb R; Dunavent J; Flood J; Barnes J
J Contemp Dent Pract; 2005 Feb; 6(1):1-9. PubMed ID: 15719071
[TBL] [Abstract][Full Text] [Related]
35. The substantivity of a number of oral hygiene products determined by the duration of effects on salivary bacteria.
Elworthy A; Greenman J; Doherty FM; Newcombe RG; Addy M
J Periodontol; 1996 Jun; 67(6):572-6. PubMed ID: 8794966
[TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy of a 0.07% cetylpyridinium chloride mouth rinse in relation to plaque and gingivitis: a 6-month randomized, vehicle-controlled clinical trial.
Van Leeuwen MP; Rosema NA; Versteeg PA; Slot DE; Van Winkelhoff AJ; Van der Weijden GA
Int J Dent Hyg; 2015 May; 13(2):93-103. PubMed ID: 25040299
[TBL] [Abstract][Full Text] [Related]
37. The effect of toothbrushing regimens on the plaque inhibitory properties of an experimental cetylpyridinium chloride mouthrinse.
Witt J; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A
J Clin Periodontol; 2006 Oct; 33(10):737-42. PubMed ID: 16899026
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of de novo plaque growth by a new 0.03 % chlorhexidine mouth rinse formulation applying a non-brushing model: a randomized, double blind clinical trial.
Mor-Reinoso C; Pascual A; Nart J; Quirynen M
Clin Oral Investig; 2016 Sep; 20(7):1459-67. PubMed ID: 26475499
[TBL] [Abstract][Full Text] [Related]
39. Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load.
Tarragó-Gil R; Gil-Mosteo MJ; Aza-Pascual-Salcedo M; Alvarez MJL; Ainaga RR; Gimeno NL; Viñuales RF; Fernández YM; Marco JM; Bolsa EA; Sancho JB; Cajo SA; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Izquierdo-Useros N; Pociello VB; León R; Peris DS
J Clin Periodontol; 2023 Mar; 50(3):288-294. PubMed ID: 36345827
[TBL] [Abstract][Full Text] [Related]
40. The efficacy of amine fluoride/stannous fluoride in the suppression of morning breath odour.
Quirynen M; Avontroodt P; Soers C; Zhao H; Pauwels M; Coucke W; van Steenberghe D
J Clin Periodontol; 2002 Oct; 29(10):944-54. PubMed ID: 12445227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
